These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27480451)

  • 1. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
    Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
    J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin.
    Aguirre TA; Rosa M; Coulter IS; Brayden DJ
    Eur J Pharm Sci; 2015 Nov; 79():102-11. PubMed ID: 26349051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
    Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
    Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres.
    Keohane K; Rosa M; Coulter IS; Griffin BT
    Drug Dev Ind Pharm; 2016; 42(2):245-53. PubMed ID: 26083078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
    Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
    Song KH; Chung SJ; Shim CK
    J Control Release; 2005 Sep; 106(3):298-308. PubMed ID: 15979756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation.
    Cetin M; Aktas MS; Vural I; Ozturk M
    J Microencapsul; 2012; 29(2):156-66. PubMed ID: 22126314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models.
    Aguirre TA; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
    Eur J Pharm Biopharm; 2014 Nov; 88(3):856-65. PubMed ID: 25445305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.
    Bandeira L; Lewiecki EM; Bilezikian JP
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):681-9. PubMed ID: 27070719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
    Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Evaluation of Enteric-Coated Chitosan Derivative-Based Microparticles Loaded with Salmon Calcitonin as an Oral Delivery System.
    Onishi H; Tokuyasu A
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.
    Tewes F; Gobbo OL; Amaro MI; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
    Mol Pharm; 2011 Oct; 8(5):1887-98. PubMed ID: 21882837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.
    Karsdal MA; Byrjalsen I; Riis BJ; Christiansen C
    BMC Clin Pharmacol; 2008 Sep; 8():5. PubMed ID: 18782439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer.
    Petersen SB; Nielsen LG; Rahbek UL; Guldbrandt M; Brayden DJ
    Eur J Pharm Sci; 2013 Mar; 48(4-5):726-34. PubMed ID: 23354154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant.
    Takatsuka S; Morita T; Koguchi A; Horikiri Y; Yamahara H; Yoshino H
    Int J Pharm; 2006 Jun; 316(1-2):124-30. PubMed ID: 16600541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flash Fabrication of Orally Targeted Nanocomplexes for Improved Transport of Salmon Calcitonin across the Intestine.
    Sun L; Le Z; He S; Liu J; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
    Mol Pharm; 2020 Mar; 17(3):757-768. PubMed ID: 32011888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs.
    Lee YH; Perry BA; Sutyak JP; Stern W; Sinko PJ
    Pharm Res; 2000 Mar; 17(3):284-90. PubMed ID: 10801216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
    du Plessis LH; Lubbe J; Strauss T; Kotzé AF
    Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.